Aquaporin-4 (AQP4), the main water-selective membrane transport protein in the brain, is localized to the astrocyte plasma membrane. 
mediators in neuroinflammatory responses. 11, 12 Activated microglia are commonly seen within the substantia nigra pars compacta (SNpc) of PD brains investigated at autopsy; these cells directly induce significant, highly detrimental neurotoxic effects by excessive production of a large array of cytotoxic factors such as interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6) and nitric oxide (NO). [13] [14] [15] Moreover, as an antigenpresenting cell (APC), activated microglia express costimulatory molecules, such as cluster of differentiation 40 (CD40), cluster of differentiation 80 (CD80; B7-1) and cluster of differentiation 86 (CD86; B7-2), that promote APC-dependent T-cell activation. [16] [17] [18] Subsequently, activated T cells injure neurons by cell contact-dependent mechanisms that involve Fas ligand (FasL) and/or release of cytotoxic factors. 19 Attenuation of microglial activation can protect up to 90% of DNs in PD animal models. [20] [21] [22] Aquaporin-4 (AQP4), originally known as a mercurial-insensitive water channel, is most strongly expressed in astrocytes throughout the brain and spinal cord, as well as in ependymal cells lining the brain ventricles; it is involved in the regulation of water homeostasis in the brain. [23] [24] [25] Recently, AQP4 expression has been reported to be involved in the pathology of the development of PD in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced mouse model. In our previous studies, compared with AQP4 +/+ mice, AQP4 −/− mice were significantly more prone to MPTP-induced neurotoxicity and subsequently exhibited significantly stronger microglial responses in the midbrain and more severe PD symptoms. [26] [27] [28] However, the mechanisms underlying hyperactive microglial responses and more severe clinical symptoms in PD after administration of MPTP in AQP4-deficient mice remain unclear.
In this study, significantly decreased transforming growth factor-β1 (TGF-β1) led to increased neuroinflammatory responses in the midbrain and more severe PD pathology in AQP4-deficient mice after MPTP intoxication. Our findings suggest a novel role for AQP4 in brain neurodegeneration and an opportunity for the development of new therapeutic approaches to treat neurodegenerative diseases.
| MATERIAL AND ME THODS

| Transgenic mice
AQP4-deficient mice were generated as previously described. on a 12-hour light/dark cycle with access to food and water. All experiments were performed on age-and weight-matched littermates (20-28 g ). Mouse breeding was performed to achieve timed pregnancy with an accuracy of ±0.5 days.
All experiments were approved by IACUC (Institutional Animal
Care and Use Committee of Nanjing Medical University). All efforts were made to minimize animal suffering and to reduce the number of animals used for the experiments.
| Acute MPTP treatment
Sixteen-week-old male AQP4 +/+ and AQP4 −/− mice were injected intraperitoneally (i.p.) four times with MPTP-HCl (20 mg/kg of free base; Sigma Chemicals, St. Louis, MO) in saline or saline alone for controls at 2-hour intervals. The total dose per mouse was 80 mg/ kg, and the mice were killed 7 days after the last injection. Mortality rates in acute MPTP-treated AQP4 −/− mice (41%, 35/85) were twofold higher than in AQP4 +/+ mice (21%, 17/80, P < 0.05). As the mice of MPTP group underwent an obvious mortality after MPTP treatment, only mice that went through all 7 days procedure were included in the following statistical analyses. MPTP handling and safety measures were in accordance with published guidelines. 
| Mesencephalic primary neuron culture and treatment
Primary mesencephalic neuronal cultures were prepared from the ventral mesencephalon of gestational 16-to 18-day-old AQP4
and AQP4 −/− mouse embryos. Mesencephalic tissues were dissected and maintained in ice-cold Ca2 + -free Hanks' Balanced Salt Solution (HBSS) (Gibco, Grand Island, NY) and then dissociated in HBSS containing trypsin-0.25% ethylenediaminetetraacetic acid (EDTA) for 20 minutes at 37°C. Dissociated cells were then plated at equal density (2 × 10 6 cells) in a 25-cm 2 flask precoated with 1 mg/mL poly-D-lysine (Sigma). Cultures were maintained in a chemically defined medium consisting of neurobasal medium fortified with B-27 supplements, 500 μg/mL of glutamine, 100 IU/mL penicillin and 100 μg/mL streptomycin (Invitrogen, Carlsbad, CA). The cells were maintained in a humidified CO 2 incubator (5% CO 2 and 37°C) for 24 hours. Half of the culture medium was replaced every 2 days. Seven-day-old cultures were used for the experiments. Primary mesencephalic DNs were exposed to 10 μmol/L MPP + (Sigma) for 24 hours.
Primary cultures of mixed glia from day 1-2 newborn mice were prepared. Briefly, following the removal of meninges, brain tissues were minced and incubated in a rocking water bath at 37°C for 30 minutes in HBSS (Gibco) in the presence of 0.25% trypsin (Sigma). Enzyme-digested dissociated cells were triturated with 0.25% of foetal bovine serum (FBS, Gibco), followed by a wash and centrifugation (300× g for 10 minutes). The pellet was resuspended in HBBS and passed through 100-μm nylon mesh, followed by a second wash and centrifugation (300× g for 10 minutes). Following dilutions with astrocyte-specific medium (Dulbecco's Essential Medium containing 1% penicillin-streptomycin, 10% FBS), the cells were plated and allowed to adhere for 1 day in a humidified CO 2 incubator at 37°C. After 24 hour, any non-adherent cells were removed, and fresh astrocyte-specific medium was added. Adherent cells were maintained in astrocyte-specific medium for 10 days with a medium change every 3-4 days. The microglia population peaked at 12-14 days in these cultures. Microglia-enriched cultures were thoroughly agitated in an orbital incubator shaker (250 rpm for 2 hours at 37°C) to remove any cells adherent to the astrocyte monolayer.
Immediately following agitation, all cells suspended in the culture medium were collected and centrifuged at 300× g for 5 minutes at for 48 hours in 0.1% serum-supplemented medium. The culture medium was collected and centrifuged at 300 g for 5 minutes, then the volume of each supernatant was adjusted to the same volume (to standardized preparations) and immediately stored at −80°C until used for TGF-β1 assay by ELISA using commercial kits.
| BV-2 cell culture
The immortalized microglial cell line BV-2, derived from raf/myc-immortalized murine neonatal microglia, was kindly provided by Prof.
Gang Hu. BV-2 cells were incubated under humidified 5% CO 2 and
Gibco) medium containing 10% FBS and 1% streptomycin and penicillin (Gibco).
| Brain homogenate preparation
Mice were sacrificed 7 days after either MPTP injection or TGF-β1 BV-2 cells in medium without TGF-β1/anti-TGF-β1 served as controls. After injection, the mice were kept in cages with a constant temperature (25°C) and humidity. They were exposed to a 12:12-hour light-dark cycle and had unrestricted access to tap water and food. Mice were killed for further study at 6 days after the MPTP injection. and CellQuest software (BD Biosciences); data were collected on 10 000 cells per condition.
| TGF-β1 administration in vivo
| Flow cytometry
| Immunohistochemistry staining
At the end of the experiments, the mice were perfused with 4%
paraformaldehyde ( and corrected against background signal levels. 
| Quantitative real-time PCR
| Western blot assays
| Statistical analysis
Data analyses and graphs were performed using spss software for These results suggested that after MPTP treatment, AQP4 deficiency results in enhanced astrocyte activation but no detectable difference in α-syn protein levels in astrocytes between AQP4 +/+ and AQP4 −/− mice.
| AQP4 −/− neurons expressed higher levels of α-syn with or without MPP + treatment
In neurons, α-syn is abundant. 42 Both our qRT-PCR ( Figure 3A) and Western blotting ( Figure 3B ,C) results showed that even without MPP + treatment, neurons from AQP4 −/− mice expressed much higher levels of α-syn than did neurons from AQP4 +/+ mice.
After MPP + treatment, α-syn mRNA expression was significantly increased in AQP4 −/− neurons but not in AQ P4 +/+ neurons.
Compared with PBS-treated AQP4 −/− neurons, MPP + -treated AQP4 −/− neurons exhibited an increasing trend in the expression of α-syn protein.
The midbrain sections of both AQP4 +/+ and AQP4 −/− mice were examined for TH and α-syn staining after MPTP treatment. Figure 3D shows Midbrain TGF-β1 is mainly expressed by microglia and astrocytes. [49] [50] [51] Since AQP4 was expressed in astrocytes but not in microglia, 28, [35] [36] [37] we further investigated the expression of TGF-β1 in Figure 6A and B show that there were no significant differences in the stereo- and IL-6, but there were no significant differences ( Figure 7C ). These data further suggested that the lower TGF-β1 level might be one of reasons in AQP4 −/− mice contributed to stronger microglial activation, which might subsequently result in more dopaminergic neuronal death and more severe PD disease after MPTP intoxication, and certain other factor(s) in brain homogenates might also be responsible for the more microgliosis and neuronal damage after MPTP treatment.
| D ISCUSS I ON
Aquaporin-4 is a predominant water channel protein in mammalian brains that is mainly localized to the astrocyte plasma membrane. 25 In our previous study, AQP4 −/− mice showed significantly stronger microglial responses and exhibited significantly more severe neuronal pathology after administration of MPTP.
28
However, the mechanisms remain unclear. In this study, for the first time, we revealed that the significantly reduced TGF-β1 in Interleukin-1β (IL-1β), tumour necrosis factor-α (TNF-α), interleukin-6 (IL-6), and transforming growth factor-β1 (TGF-β1) levels (C) were determined using ELISA. The data are expressed as the mean ± SD, n = 6. *P < 0.05, **P < 0.01, ***P < 0.001, compared with MPTP-injected AQP4 −/− mice (differential expression of CD80 and CD40 surface molecules and pro/anti-inflammatory cytokines) and neuronal damage after MPTP treatment. The PD protein α-syn may play a role in microglial activation in the substantia nigra in PD and the levels of MHCII, a classical pro-inflammatory molecule. 38, 55, 56 However, in this study, after MPTP treatment, AQP4 +/+ mice showed significant neuronal pathology but only very low levels of α-syn.
In addition, the level of endogenous α-syn was much higher in AQP4 −/− mice than in AQP4 +/+ mice without MPTP treatment.
Thus, these results indicate that high levels of α-syn alone may be insufficient to induce neuronal pathology. Instead, previous studies showed that α-syn may play an adjunctive role in PD by enhancing microglial activation-mediated neuronal pathology, which is triggered by certain factors that are necessary for the onset of PD (eg, MPTP). Previous studies 57 and our studies suggested the high level of α-syn may make AQP4 −/− mice more susceptible to MPTP, but the mechanism still needs to be fur- 43 Moreover, TGF-β1 elicits the neurotrophic activity of glial cell-derived neurotrophic factor (GDNF) and contributes to the survival of midbrain DNs to protect against the toxic effects of MPP + . 59 In this study, for the first time, we showed that AQP4 deficiency in mice resulted in the failure to increase TGF-β1 production in the midbrain and peripheral blood after MPTP treatment; these changes might account for the hyperactive microglial neuroinflammatory responses and enhanced loss of DNs by MPTP-induced neurotoxicity. Our observation appears to support the notion that reduced TGF-β1 signalling in the striatum contributes to the loss of DNs in the substantia nigra. 48 The primary cell types expressing TGF-β1 mRNA in the adult brain are microglia and astrocytes. 49, 51 According to previous research, astrocytes but not microglia express AQP4. 25, 28, [35] [36] [37] In this study, we further demonstrated that MPP + treatment failed to increase TGF-β1 production in AQP4 −/− astrocytes. However, since TGF-β1 can be produced by cells other than astrocytes in the brain, further studies are needed to explore how AQP4 controls astrocytes and/or other cells to generate TGF-β1.
| CON CLUS IONS
Our study illustrated that the TGF-β1 production in astrocytes was impaired in AQP4 −/− mice; this alteration may contribute to the hyperactive microglial neuroinflammatory responses and subsequent enhancement of the loss of DNs by MPTP-induced neurotoxicity.
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